# Fluorescence-Guided Surgical Resection for Reducing Unexpected Positive Margins in Patients With Sarcoma, SarcoSIGHT Trial

> **NCT07650656** · PHASE2 · RECRUITING · sponsor: **City of Hope Medical Center** · enrollment: 22 (estimated)

## Conditions studied

- High Grade Sarcoma
- Sarcoma

## Interventions

- **OTHER:** Electronic Health Record Review
- **PROCEDURE:** Fluorescence Imaging
- **PROCEDURE:** Fluorescence-Guided Surgery
- **DRUG:** Indocyanine Green
- **OTHER:** Questionnaire Administration
- **PROCEDURE:** Resection

## Key facts

- **NCT ID:** NCT07650656
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2027-05-15
- **Primary completion:** 2028-05-11
- **Final completion:** 2028-05-11
- **Target enrollment:** 22 (ESTIMATED)
- **Last updated:** 2026-06-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07650656

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07650656, "Fluorescence-Guided Surgical Resection for Reducing Unexpected Positive Margins in Patients With Sarcoma, SarcoSIGHT Trial". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07650656. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*